The global Alzheimer’s disease treatment market consists of sales of drugs used to treat Alzheimer’s disease. Alzheimer`s disease is a progressive neurological disorder causing degeneration of brain cells, resulting in dementia (a condition that causes a decline in thinking, behavioral and social skills). The progression of this disease causes severe memory impairment and the person may lose the ability to carry out everyday tasks.
The global Alzheimer’s disease treatment market is expected to decline from $3.46 billion in 2019 to $3.42 billion in 2020 at a compound annual growth rate (CAGR) of -1.26%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $4.96 billion in 2023 at a CAGR of 13.21%.
